MOLECULAR MODELING OF THE P2Y12 COMPLEX OF HUMAN RECEPTOR WITH R-138727 MOLECULE

Abstract

The leading cause of human death throughout the world is atherothrombosis of various localization. The key point in the fight against this pathology is the appointment of antiplatelet agents. These drugs differ from each other in the mechanism of inhibiting platelet activity. Prasugrel, an antagonist of the thienopyridine class, is a potent inhibitor of platelet activation and aggregation mediated by platelet ADP receptors of the P2Y12 class.